Celyad Oncology SA provides update of total number of voting rights and shares.

M2 EQUITYBITES-December 31, 2021-Celyad Oncology SA provides update of total number of voting rights and shares

(C)2021 M2 COMMUNICATIONS http://www.m2.com

Biotechnology company Celyad Oncology SA (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) on Friday announced the issuance of 6,500,000 new shares to an affiliate of Fortress Investment Group under Article 15 of the Belgian Law.

Following the issue, the company's share capital rose to EUR78.58m and is represented by 22,593,956 shares.

The total number of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT